# Assessment of Quitting Versus Using Aspirin Therapy In Patients Treated With Oral Anticoagulation for Atrial Fibrillation or Other Indication With Stabilized Coronary Artery Disease

Study · id `cardio:ct-nct04217447` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04217447](<https://clinicaltrials.gov/study/NCT04217447>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04217447

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Stroke; Heart rhythm problems  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 874 participants.

## Technical summary

Registry record NCT04217447. Randomized; quadruple masking; primary purpose treatment. Start 2020-05-25 (actual); primary completion 2024-10-28 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 874 participants (enrolled count; ClinicalTrials.gov record NCT04217447, source copy `cardio:ctgov-nct04217447-2025-07-10`, retrieved 2026-10-26)
- Started: 2020-05-25 (actual) (ClinicalTrials.gov record NCT04217447, source copy `cardio:ctgov-nct04217447-2025-07-10`, retrieved 2026-10-26)
- Primary completion: 2024-10-28 (actual) (ClinicalTrials.gov record NCT04217447, source copy `cardio:ctgov-nct04217447-2025-07-10`, retrieved 2026-10-26)
- Completion: 2024-10-28 (actual) (ClinicalTrials.gov record NCT04217447, source copy `cardio:ctgov-nct04217447-2025-07-10`, retrieved 2026-10-26)
- Countries: France (ClinicalTrials.gov record NCT04217447, source copy `cardio:ctgov-nct04217447-2025-07-10`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04217447-2025-07-10`, retrieved 2026-10-26)

## The registry's words

- Brief title: Assessment of Quitting Versus Using Aspirin Therapy In Patients Treated With Oral Anticoagulation for Atrial Fibrillation or Other Indication With Stabilized Coronary Artery Disease
- Acronym: AQUATIC
- Condition: Coronary Artery Disease
- Intervention (Drug): OAC + Aspirin 100mg od
- Intervention (Drug): OAC + placebo of Aspirin 100mg od
- Lead sponsor: University Hospital, Brest
- Lead sponsor class: OTHER
- Collaborator: Bayer
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: University Hospital, Brest (`cardio:org-university-hospital-brest`)
- Registry lists this organization as a collaborator: Bayer (`cardio:bayer`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (`cardio:pubmed-40888725`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: a260dfaaae0d9ad1a9a54c4aa7d54a731483229d6a032d6e1f7e49ce1db013a2
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
